 low-dos recombin human erythropoietin therapi chronic hemodialysi patient hypothesi low-dos recombin human erythropoietin r-huepo effect safe therapi anemia end-stag renal failur chronic hemodialysi patient month month treatment r-huepo IV time hematocrit mean vol target rang mean vol increas month transfus requir patient new develop hypertens trial dose vascular access thrombosi dialyz clot seizur r-huepo therapi dialyz reus low-dos r-huepo therapi effect hemodialysi patient advers effect increas blood viscos target downward dosag adjust initi low-dos regimen